Patent 7166445 was granted and assigned to Immunex on January, 2007 by the United States Patent and Trademark Office.
The invention provides improved methods of recombinant protein production in cell culture. More specifically, the invention relates to the modulation of the IGF-1 signaling pathway in cells so as to improve production characteristics.